Brief: Aeterna Zentaris Commences Pivotal Phase 3 Detect-Trial For The Diagnosis Of Childhood-Onset Growth Hormone Deficiency

COSCIENS Biopharma

13/05/2021 13:58

May 13 (Reuters) - Aeterna Zentaris Inc  AEZS.TO :
    * AETERNA ZENTARIS INC - PATIENT ENROLLMENT ON TRACK TO
START THIS
QUARTER
    * AETERNA ZENTARIS INC - SAFETY AND EFFICACY STUDY FOR
MACIMORELIN
INITIATED AS AGREED WITH U.S. FDA AND EMA IN PEDIATRIC
INVESTIGATION PLAN
    * AETERNA ZENTARIS INC - PLANNED COMPLETION OF PIVOTAL PHASE
3
STUDYEXPECTED IN Q3 2022

Source text for Eikon:  ID:nGNXb0TFL0 
Further company coverage:  AEZS.TO 

 ((Reuters.Briefs@thomsonreuters.com;))